Recent developments in the biology and medicinal chemistry of CDK9 inhibitors: an update

T Wu, Z Qin, Y Tian, J Wang, C Xu, Z Li… - Journal of medicinal …, 2020 - ACS Publications
Cyclin-dependent kinase 9 (CDK9), which regulates transcriptional elongation, is an
attractive therapeutic target for many cancers, especially for cancers driven by transcriptional …
被引用次数：62 相关文章

Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update

T Wu, Z Qin, Y Tian, J Wang, C Xu… - Journal of medicinal …, 2020 - pubmed.ncbi.nlm.nih.gov
Cyclin-dependent kinase 9 (CDK9), which regulates transcriptional elongation, is an
attractive therapeutic target for many cancers, especially for cancers driven by transcriptional …

Recent Developments in the Biology and Medicinal Chemistry of CDK9 Inhibitors: An Update.

T Wu, Z Qin, Y Tian, J Wang, C Xu, Z Li… - Journal of Medicinal …, 2020 - europepmc.org
Cyclin-dependent kinase 9 (CDK9), which regulates transcriptional elongation, is an
attractive therapeutic target for many cancers, especially for cancers driven by transcriptional …